Approximately 20% of primary care patients in the U.S. drink alcohol (ethanol) at levels harmful to health.
| Test Name and Number | Recommended Use | Limitations | Follow Up |
|---|---|---|---|
| CBC with Platelet Count 0040002 Method: Automated Cell Count |
Initial test to determine macrocytosis |
||
| Hepatic Function Panel 0020416 Method: Quantitative Enzymatic/Quantitative Spectrophotometry |
Initial screen for suspected alcohol related hepatic injury Panel includes albumin, alkaline phosphatase, AST, ALT, direct bilirubin, total protein, and total bilirubin |
||
| Ethanol, Serum or Plasma - Medical 0090120 Method: Quantitative Gas Chromatography/Enzymatic |
One of the screens used to identify acute alcohol use |
Assay detection limit varies based on instrumentation |
|
| Alcohols 0090131 Method: Quantitative Gas Chromatography |
Best test to identify acute use of ethanol, methanol, or isopropanol Acetone is also detected |
Assay detection limit is 5 mg/dL |
|
| Drugs of Abuse Test, Alcohol, Urine - Screen with Reflex to Confirmation/Quantitation 0092280 Method: Semi-Quantitative Alcohol Dehydrogenase/ Qualitative Gas Chromatography-Flame Ionization Detection |
Identify acute alcohol use Screen with reflex to confirmation |
Sensitivity and specificity with urine are relatively poor; not valid for forensic use Positive cutoff 40 mg/dL |
|
| Gamma Glutamyl Transferase, Serum or Plasma 0020009 Method: Quantitative Enzymatic |
Determine if ALT/AST elevation is hepatic pattern |
May be less sensitive marker in young drinkers Not specific for alcohol abuse; may be elevated in nonalcoholic fatty liver disease, drug intoxication, or other liver diseases |
|
| Carbohydrate Deficient Transferrin for Alcohol Use 0070412 Method: Quantitative Electrophoresis |
Identify alcohol abuse or abuse relapse; will detect chronic ethanol use (≥40 g/day for 2 weeks) More sensitive in men |
Rare transferrin genetic variants may interfere with analysis Advanced liver damage (including severe chronic viral hepatitis) and anti-epileptic drug therapy can increase CDT levels Not recommended for general population screening |
|
| Ethyl Glucuronide, Urine - Screen with Reflex to Confirmation/Quantitation 2003189 Method: Qualitative Enzyme Immunoassay/Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry |
Detect recent ethanol exposure; monitor alcohol abstinence |